APRE
APRE
NASDAQ · Biotechnology

Aprea Therapeutics Inc

$0.69
+0.07 (+10.51%)
As of Feb 8, 2:32 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.10M 1.13M 1.14M
Net Income 89.2K 117.7K 115.4K
EPS
Profit Margin 8.1% 10.4% 10.1%
Rev Growth +5.3% -7.0% -3.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 493.4K 556.8K 520.5K
Total Equity 2.95M 2.97M 2.85M
D/E Ratio 0.17 0.19 0.18
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 177.4K 182.1K 193.3K
Free Cash Flow 70.9K 72.7K 77.2K